Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by TurtleNamedSamon Jan 04, 2016 11:47pm
113 Views
Post# 24429464

RE:RE:Cresccita proposal...

RE:RE:Cresccita proposal...From the news release:

...today announced that it will hold a special meeting of Nuvo's shareholders on February 18, 2016 at which shareholders will be asked to approve the previously announced reorganization of Nuvo into two separate publicly traded companies. ...

The Board of Directors of Nuvo has unanimously approved the proposed transaction and recommends that shareholders vote in favour of the proposed transaction.

The terms of the proposed transaction are set out in an arrangement agreement (and the plan of arrangement appended thereto) that will be available under Nuvo's profile at www.sedar.com within 10 days.  Completion of the proposed transaction is subject to certain conditions, including the approval of the Ontario Superior Court of Justice, the final approval of the Toronto Stock Exchange and the approval of Nuvo's shareholders.  If the proposed transaction is approved by shareholders and all other conditions are satisfied, Nuvo expects the transaction to be completed in Q1 2016.  However, there can be no assurances regarding the ultimate timing of the proposed transaction or that the proposed transaction will be completed at all.  Even if the proposed transaction is approved by shareholders and all other conditions are satisfied, Nuvo's Board of Directors will have the authority to determine when to effect the proposed transaction, as well as the authority to decide not to proceed with the proposed transaction at all.
 


Bullboard Posts